Chargement en cours...
Lamellar macular hole after intravitreal ocriplasmin injection
Intravitreal ocriplasmin was recently approved by the Food and Drug Administration to achieve medical vitreolysis in the setting of vitreomacular adhesion (VMA). We report a case of a 76-year-old woman who developed a lamellar macular hole following treatment with intravitreal ocriplasmin injection...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289753/ https://ncbi.nlm.nih.gov/pubmed/25576512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-207810 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|